---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-000516"
form_type: "8-K"
ticker: "AGL"
cik: "0001831097"
company_name: "agilon health, inc."
filed_at: "2024-01-05T23:59:59+00:00"
generated_at: "2026-06-07T03:21:51.616585+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# agilon health cuts 2023 medical margin guidance by ~$110M; withdraws 2026 outlook

## Summary
- 2023 medical margin guidance lowered to $340M-$360M from $455M-$470M, a ~$110M reduction.
- 2023 Adjusted EBITDA guidance revised to loss of $55M-$69M from prior profit of $6M-$18M.
- Higher-than-expected medical costs from specialist visits, Part B drugs, outpatient surgeries cited.
- Initial 2024 outlook: medical margin $560M-$600M; Adjusted EBITDA $40M-$60M.
- Withdraws previously issued 2026 target; actions underway to improve predictability.

## SEC filing metadata
- accession: 0001628280-24-000516
- form_type: 8-K
- ticker: AGL
- cik: 0001831097
- company_name: agilon health, inc.
- filed_at: 2024-01-05T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831097/000162828024000516/0001628280-24-000516-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831097/000162828024000516/agl-20240105.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-000516
- JSON: https://secwatch.observer/filing/0001628280-24-000516.json
- Plain text: https://secwatch.observer/filing/0001628280-24-000516.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.